“MGMT Promoter Methylation and Survival in IDH-Wildtype vs. IDH-Mutant Anaplastic Astrocytomas”

https://pubmed.ncbi.nlm.nih.gov/38114801

MGMT promoter methylation is associated with improved overall survival in patients with IDH-wildtype anaplastic astrocytomas, but not in those with IDH-mutant astrocytomas.